Back to Journals » Neuropsychiatric Disease and Treatment » Volume 19

Perinatal Mental Health Disorders: A Review of Lessons Learned from Obstetric Care Settings

Authors Ayala NK , Lewkowitz AK, Whelan AR, Miller ES

Received 4 January 2023

Accepted for publication 17 February 2023

Published 23 February 2023 Volume 2023:19 Pages 427—432

DOI https://doi.org/10.2147/NDT.S292734

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Roger Pinder



Nina K Ayala,1,2 Adam K Lewkowitz,1,2 Anna R Whelan,1,2 Emily S Miller1,2

1Division of Maternal Fetal Medicine, Women and Infants Hospital of Rhode Island, Providence, RI, USA; 2Department of Obstetrics and Gynecology, Alpert Medical School of Brown University, Providence, RI, USA

Correspondence: Nina K Ayala, Division of Maternal Fetal Medicine, Women & Infants Hospital of Rhode Island, 101 Dudley Street, Providence, RI, 02905, USA, Tel +1 401-274-1122, ext. 43435, Email [email protected]

Abstract: Perinatal mental health has garnered significant attention within obstetrics over the last couple of decades as the long- and short-term morbidities of untreated perinatal mental health disorders on both the mother and fetus/neonate have become increasingly apparent. There have been major strides in increasing screening for perinatal mental health disorders, clinician comfort with prescribing common psychiatric medications, and integrating mental health professionals into prenatal care via health services approaches such as the collaborative care model. Despite these advances, however, gaps still remain in the tools used for screening and diagnosis, obstetric clinician training in diagnosis and management of perinatal mood and anxiety disorders, as well as patient access to mental health care during pregnancy and especially postpartum. Herein we review the state of perinatal mental health from the perspective of the obstetric provider and identify areas of ongoing innovation.

Keywords: perinatal mental health, perinatal depression, perinatal anxiety, collaborative care

Introduction

Over the last couple of decades, there has been a paradigm shift in perinatal health care where mental health has been recognized as a major contributor to perinatal and fetal/neonatal wellness. Perinatal mood and anxiety disorders (PMAD) are among the most common pregnancy complications, impacting up to 1 in 5 women.1 Untreated or undertreated PMAD are associated with major short- and long-term morbidities for both the mother and fetus/neonate including preterm birth, small for gestational age, compromised maternal-infant bonding, worsening PMAD symptom trajectory and, in rare cases, maternal mortality.2–9 The gap in diagnosis and treatment of PMAD is further exacerbated by the major social, racial and ethnic inequities that pervade maternal healthcare overall.10–12

Many of the contributors to PMAD such as social stressors and pre-existing psychiatric conditions including anxiety, depression and post-traumatic stress disorders were exacerbated by the COVID-19 pandemic.13–18 Challenges in access to care during the pandemic have also disproportionately impacted underrepresented and minoritized populations, compounding existing care gaps and brought additional attention to this area.19,20

Existing Barriers

Screening

National organizations such as the American College of Obstetricians and Gynecologists (ACOG), the United States Preventive Services Task Force (USPSTF), the National Institute for Health and Care Excellence (NICE), as well as others, have emphasized the importance of universal screening for and active management of PMAD.2,21–25 Many of these organizations support screening at least once during pregnancy; however, there is little consensus or guidance about the optimal period in pregnancy that screening should be performed, and some guidelines even provide contradictory recommendations.24,25 The lack of guidance has resulted in incredibly varied practices where patients are inconsistently screened during pregnancy or never screened at all,26 which may miss opportunities for active management of PMAD. There is also a lack of consensus about how sub-clinical PMAD (scores that fall just below the threshold for a positive screen) should be managed. For example, do they require repeat screening, and if so, at what interval would screening optimally be performed?

Furthermore, there are significant time constraints to addressing all relevant perinatal issues in the context of standard prenatal visits. Due to a shortage of obstetric care providers,27 clinicians are frequently allocated less than 15 minutes per visit to address all preventive obstetric care as well as problems that have arisen. Particularly within the context of a medically complicated pregnancy, mental health can easily be pushed aside for other, seemingly more pressing issues. Furthermore, the most commonly utilized screening tools, such as the Edinburgh Postnatal Depression Scale (EPDS)28 and the Patient Health Questionnaire-9 (PHQ-9)29 were developed and validated in pregnant populations that do not mirror most modern obstetric landscapes. There has been a push to develop culturally diverse mental health screening tools in the non-perinatal population;30–33 however, these efforts have yet to be rigorously applied to the perinatal sphere.

Recently, additional attention has been paid to the various conditions that are frequently comorbid with PMAD, particularly substance use disorders34 and intimate partner violence (IPV).35 Pregnancy provides a unique opportunity to identify for these comorbidities along with PMAD, and screening for both substance use and IPV is encouraged at least once in pregnancy as part of comprehensive obstetric care.34,35

Unfortunately, perinatal mental health screening has not been a robust aspect of obstetric training. Specifically, few obstetric providers receive dedicated training in responding to positive responses on depression screens, and even less training on responding to findings concerning for suicidality, which can serve as a deterrent to regular screening practices.36,37

Treatment

Even if an obstetric provider feels comfortable screening for PMAD, most receive inadequate training on even basic management of these disorders.38 Lack of knowledge around safe medication prescribing patterns in the perinatal period as well as the inability to provide interpersonal therapy options can make it challenging or uncomfortable for obstetric providers to initiate treatment in this population.37–40 This is compounded by discomfort by many mental health specialists in treating pregnant or recently postpartum individuals and the shortage of perinatal mental health specialists,41,42 which creates additional barriers to helping patients access comprehensive mental health care. These barriers are particularly challenging for pregnant or postpartum individuals with public insurance.43,44

Access to Postpartum Care

Postpartum visit attendance is incredibly variable, with 25–96% of people attending a postpartum visit.45 Among vulnerable populations, this can be as low as 30–50%,46 with racial/ethnic minority populations, particularly Black women, having among the lowest rates due to structural racism and adverse social determinants of health.47 Postpartum telehealth options that were introduced during the COVID-19 pandemic have been shown to mitigate existing disparities in postpartum care access and uptake,48 but optimal implementation of postpartum telehealth, accounting for the need for a physical examination and potential placement of long-acting reversible contraceptives (LARC) has not been established.

Ongoing Areas of Innovation

Education

Recognizing the gaps in perinatal mental health education during psychiatry training, The National Task force in Women’s Reproductive Mental Health recently launched the National Curriculum in Reproductive Psychiatry (NCRP).49 This online, interactive training platform is tailored to mental health professionals and trainees, and was designed to deepen the knowledge of psychiatric issues that arise during the reproductive years. In a recent call to action on the importance of cultivating mental health in obstetrics and gynecology, creators of the NCRP revealed the plan to develop a curriculum oriented toward obstetric trainees that will be modeled after the NCRP.50 The consistent gaps in education on perinatal mental health across both psychiatric and obstetric training programs highlight that there may be untapped opportunities for collaborative learning across specialties. This could also foster open sharing of resources and help develop cooperative care networks and research infrastructure.

Collaborative Care Model

Integrated models of care, such as the collaborative care model, have garnered significant attention as a mechanism to increase access to and quality of perinatal mental health care.51–53 They involve convening a multidisciplinary team of obstetric providers, perinatal psychiatrists, case managers, social workers, among others who actively follow-up PMAD screening, funnel resources to those with active concerns, and encourage targeted treatment-to-goal throughout the perinatal period for a population of pregnant and postpartum people. They have been demonstrated to increase obstetric clinician comfort with screening and prescribing,54 as well as mitigation of extant disparities in perinatal mental health care.1,55 However, there are some barriers to widespread implementation of this care model. Its implementation is time-intensive and personnel-intensive as it requires regular, ongoing multidisciplinary care. It also relies on regular screening and an ongoing system-wide commitment to incorporating mental health into routine perinatal care.

Partner Mental Health

Up to 8–10% of non-birthing partners (or depending on the study examined, fathers) experience PMAD,56–58 which has major implications for their health as well as the health of the birthing parent57,59–62 and their offspring.63,64 PMAD in the non-birthing person can be more challenging to diagnose due to the lack of consistent health care or screening, differences in the manifestation of PMAD by gender,65,66 and social stigma around seeking help for mental health indications. Improving partner mental health is an innovative way of positively impacting birthing-person mental health and related outcomes.67

Resilience

Prior perinatal mental health research and innovation has largely been viewed through a pathological, Diagnostic and Statistical Manual of Mental Disorders (DSM) perspective. Improving somatic, birth experience, and mental health outcomes through bolstering maternal resilience remains an underappreciated and understudied area at the cross-section of obstetrics and mental health,68 but one that has shown promise in non-obstetric populations.69,70

Conclusions

Despite huge strides in understanding, screening for, and treating PMAD, much remains unknown. A number of innovative strategies to address some of the remaining gaps include structured trainee education in perinatal mental health, optimizing care access to vulnerable populations, establishing collaborative care models, improving partner mental health and harnessing improvements in resilience. Obstetric providers have a unique role as the primary care providers for most patients in the peripartum period, which is an underappreciated window into future health.

Disclosure

AKL serves on the medical advisory boards for Pharmacosmos Therapeutics, Incorporated and Shields Pharmaceuticals for the last 3 years. AKL is also supported by the NICHD (K23 HD103961) and reports grants and personal fees from Pharmacosmos Therapeutics, Incorporate. NKA is supported by the Robert A. Winn Diversity in Clinical Trials Career Development Award, funded by Gilead Sciences. The authors report no other conflicts of interest in this work.

References

1. World Health Organization. Maternal mental health; 2021. Available from: https://www.who.int/mental_health/maternal-child/maternal_mental_-health/en/. Accessed December 1, 2022.

2. ACOG Committee. ACOG committee opinion No. 757: screening for perinatal depression. Obstet Gynecol. 2018;132(5):e208–e212. doi:10.1097/AOG.0000000000002927

3. Jarde A, Morais M, Kingston D, et al. Neonatal outcomes in women with untreated antenatal depression compared with women without depression: a systematic review and meta-analysis. JAMA Psychiatry. 2016;73(8):826–837. doi:10.1001/jamapsychiatry.2016.0934

4. Gentile S. Untreated depression during pregnancy: short- and long-term effects in offspring. A systematic review. Neuroscience. 2017;342:154–166. doi:10.1016/j.neuroscience.2015.09.001

5. Wisner KL, Sit DKY, McShea MC, et al. Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. JAMA Psychiatry. 2013;70(5):490. doi:10.1001/jamapsychiatry.2013.87

6. Admon LK, Dalton VK, Kolenic GE, et al. Trends in suicidality 1 year before and after birth among commercially insured childbearing individuals in the United States, 2006–2017. JAMA Psychiatry. 2021;78(2):171–176. doi:10.1001/jamapsychiatry.2020.3550

7. Goldman-Mellor S, Margerison CE. Maternal drug-related death and suicide are leading causes of postpartum death in California. Am J Obstet Gynecol. 2019;221(5):489.e1–489.e9. doi:10.1016/j.ajog.2019.05.045

8. Metz TD, Rovner P, Hoffman MC, Allshouse AA, Beckwith KM, Binswanger IA. Maternal deaths from suicide and overdose in Colorado, 2004–2012. Obstet Gynecol. 2016;128(6):1233–1240. doi:10.1097/AOG.0000000000001695

9. Howard LM, Khalifeh H. Perinatal mental health: a review of progress and challenges. World Psychiatry off J World Psychiatr Assoc WPA. 2020;19(3):313–327. doi:10.1002/wps.20769

10. Admon LK, Winkelman TNA, Zivin K, Terplan M, Mhyre JM, Dalton VK. Racial and Ethnic disparities in the incidence of severe maternal morbidity in the United States, 2012–2015. Obstet Gynecol. 2018;132(5):1158–1166. doi:10.1097/AOG.0000000000002937

11. Carter EB, Mazzoni SE. A paradigm shift to address racial inequities in perinatal healthcare. Am J Obstet Gynecol. 2021;224(4):359–361. doi:10.1016/j.ajog.2020.11.040

12. Sutton MY, Anachebe NF, Lee R, Skanes H. Racial and ethnic disparities in reproductive health services and outcomes, 2020. Obstet Gynecol. 2021;137(2):225–233. doi:10.1097/AOG.0000000000004224

13. Corbett GA, Milne SJ, Hehir MP, Lindow SW, O’connell MP. Health anxiety and behavioural changes of pregnant women during the COVID-19 pandemic. Eur J Obstet Gynecol Reprod Biol. 2020;249:96–97. doi:10.1016/j.ejogrb.2020.04.022

14. Rashidi Fakari F, Simbar M. Coronavirus pandemic and worries during pregnancy; a letter to editor. Arch Acad Emerg Med. 2020;8(1):e21.

15. Ryan GA, Purandare NC, McAuliffe FM, Hod M, Purandare CN. Clinical update on COVID-19 in pregnancy: a review article. J Obstet Gynaecol Res. 2020;46(8):1235–1245. doi:10.1111/jog.14321

16. Thapa SB, Mainali A, Schwank SE, Acharya G. Maternal mental health in the time of the COVID-19 pandemic. Acta Obstet Gynecol Scand. 2020;99(7):817–818. doi:10.1111/aogs.13894

17. Werner EA, Aloisio CE, Butler AD, et al. Addressing mental health in patients and providers during the COVID-19 pandemic. Semin Perinatol. 2020;44(7):151279. doi:10.1016/j.semperi.2020.151279

18. Osborne LM, Kimmel MC, Surkan PJ. The crisis of perinatal mental health in the age of covid-19. Matern Child Health J. 2021;25(3):349–352. doi:10.1007/s10995-020-03114-y

19. van DA, Cooney RE, Sabin ML. COVID-19 exacerbating inequalities in the US. Lancet Lond Engl. 2020;395(10232):1243–1244. doi:10.1016/S0140-6736(20)30893-X

20. Gomez-Roas MV, Davis KM, Leziak K, et al. Postpartum during a pandemic: challenges of low-income individuals with healthcare interactions during COVID-19. PLoS One. 2022;17(5):e0268698. doi:10.1371/journal.pone.0268698

21. Siu AL, Bibbins-Domingo K, Grossman DC, et al.; US Preventive Services Task Force (USPSTF). Screening for depression in adults: US preventive services task force recommendation statement. JAMA. 2016;315(4):380. doi:10.1001/jama.2015.18392

22. American Psychological Association. Position statement on screening and treatment of mood and anxiety disorders during pregnancy and postpartum. Available from: https://www.psychiatry.org/file%20library/about-apa/organization-documents-policies/policies/positionscreening-and-treatment-mood-anxiety-disorders-during-pregnancy-postpartum.pdf. Accessed December 1, 2022.

23. Earls MF, Yogman MW, Mattson G, et al. Incorporating recognition and management of perinatal depression into pediatric practice. Pediatrics. 2019;143(1):e20183259. doi:10.1542/peds.2018-3259

24. Surveillance report 2017 – antenatal and postnatal mental health: clinical management and service guidance (2014) NICE guideline CG192. National Institute for Health and Care Excellence (NICE); 2017. Available from: http://www.ncbi.nlm.nih.gov/books/NBK550943/. Accessed February 19, 2023.

25. National Institute for Health and Care Excellence (NICE). Antenatal Care for Uncomplicated Pregnancies; 2019. Available from: http://www.ncbi.nlm.nih.gov/books/NBK552849/. Accessed February 10, 2023.

26. Avalos LA, Raine-Bennett T, Chen H, Adams AS, Flanagan T. Improved perinatal depression screening, treatment, and outcomes with a universal obstetric program. Obstet Gynecol. 2016;127(5):917–925. doi:10.1097/AOG.0000000000001403

27. Stonehocker J, Muruthi J, Rayburn WF. Is there a shortage of obstetrician-gynecologists? Obstet Gynecol Clin North Am. 2017;44(1):121–132. doi:10.1016/j.ogc.2016.11.006

28. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry J Ment Sci. 1987;150:782–786. doi:10.1192/bjp.150.6.782

29. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi:10.1046/j.1525-1497.2001.016009606.x

30. Roy T, Lloyd CE. Cultural applicability of screening tools for measuring symptoms of depression. In: Lloyd CE, Pouwer F, Hermanns N, editors. Screening for Depression and Other Psychological Problems in Diabetes. Springer London; 2013:67–86.

31. Wong R, Wu R, Guo C, Lam JK, Snowden LR. Culturally sensitive depression assessment for Chinese American Immigrants: development of a comprehensive measure and a screening scale using an item response approach. Asian Am J Psychol. 2012;3(4):230–253. doi:10.1037/a0025628

32. Abas MA, Phillips C, Carter J, Walter J, Banerjee S, Levy R. Culturally sensitive validation of screening questionnaires for depression in older African–Caribbean people living in south London. Br J Psychiatry. 1998;173(3):249–254. doi:10.1192/bjp.173.3.249

33. Russell SG, Quigley R, Thompson F, et al. Culturally Appropriate assessment of depression and anxiety in Older Torres Strait Islanders: limitations and recommendations. Clin Gerontol. 2022:1–13. doi:10.1080/07317115.2022.2086090

34. ACOG Committee on Health Care for Underserved Women, American Society of Addiction Medicine. ACOG committee opinion No. 524: opioid abuse, dependence, and addiction in pregnancy. Obstet Gynecol. 2012;119(5):1070–1076. doi:10.1097/AOG.0b013e318256496e

35. ACOG Committee. ACOG committee opinion No 518: intimate partner violence. Obstet Gynecol. 2012;119(2 Pt 1):412–417. doi:10.1097/AOG.0b013e318249ff74

36. Dietrich AJ, Williams JW, Ciotti MC, et al. Depression care attitudes and practices of newer obstetrician-gynecologists: a national survey. Am J Obstet Gynecol. 2003;189(1):267–273. doi:10.1067/mob.2003.410

37. Williams S, Bruxner G, Ballard E, Kothari A. Prescribing antidepressants and anxiolytic medications to pregnant women: comparing perception of risk of foetal teratogenicity between Australian obstetricians and gynaecologists, speciality trainees and upskilled general practitioners. BMC Pregnancy Childbirth. 2020;20(1):618. doi:10.1186/s12884-020-03293-0

38. Garbarino AH, Kohn JR, Coverdale JH, Kilpatrick CC. Current trends in psychiatric education among obstetrics and gynecology residency programs. Acad Psychiatry J Am Assoc Dir Psychiatr Resid Train Assoc Acad Psychiatry. 2019;43(3):294–299. doi:10.1007/s40596-019-01018-w

39. Leddy MA, Lawrence H, Schulkin J. Obstetrician-gynecologists and women’s mental health: findings of the collaborative ambulatory research network 2005–2009. Obstet Gynecol Surv. 2011;66(5):316–323. doi:10.1097/OGX.0b013e31822785ee

40. Coleman VH, Carter MM, Morgan MA, Schulkin J. United States obstetrician-gynecologists’ accuracy in the simulation of diagnosing anxiety disorders and depression during pregnancy. J Psychosom Obstet Gynaecol. 2008;29(3):173–184. doi:10.1080/01674820701833265

41. Hawkins M An Overview of the salaries, bonuses, and other incentives customarily used to recruit physicians, physician assistants and nurse practitioners; 2016.

42. AAMC. Addressing the escalating psychiatrist shortage. Available from: https://www.aamc.org/news-insights/addressing-escalating-psychiatrist-shortage. Accessed December 28, 2022.

43. Raphael JL, Patel M. Extending public insurance postpartum coverage: implications for maternal and child health. Pediatr Res. 2022;91(4):725–726. doi:10.1038/s41390-022-01949-5

44. Margerison CE, Hettinger K, Kaestner R, Goldman-Mellor S, Gartner D. Medicaid expansion associated with some improvements in perinatal mental health: study examines Medicaid expansion and perinatal mental health. Health Aff. 2021;40(10):1605–1611. doi:10.1377/hlthaff.2021.00776

45. Attanasio LB, Ranchoff BL, Cooper MI, Geissler KH. Postpartum visit attendance in the United States: a systematic review. Womens Health Issues off Publ Jacobs Inst Womens Health. 2022;32(4):369–375. doi:10.1016/j.whi.2022.02.002

46. Masho SW, Cha S, Karjane N, et al. Correlates of postpartum visits among Medicaid recipients: an analysis using claims data from a managed care organization. J Womens Health. 2018;27(6):836–843. doi:10.1089/jwh.2016.6137

47. Thiel de Bocanegra H, Braughton M, Bradsberry M, Howell M, Logan J, Schwarz EB. Racial and ethnic disparities in postpartum care and contraception in California’s Medicaid program. Am J Obstet Gynecol. 2017;217(1):47.e1–47.e7. doi:10.1016/j.ajog.2017.02.040

48. Kumar NR, Arias MP, Leitner K, Wang E, Clement EG, Hamm RF. Assessing the impact of telehealth implementation on postpartum outcomes for Black birthing people. Am J Obstet Gynecol MFM. 2022;100831. doi:10.1016/j.ajogmf.2022.100831

49. National Curriculum Reproductive Psychiatry. National curriculum in reproductive psychiatry. Available from: http://ncrptraining.org/. Accessed December 5, 2022.

50. Hutner LA, Yeaton-Massey A, Toscano M, et al. Cultivating mental health education in obstetrics and gynecology: a call to action. Am J Obstet Gynecol MFM. 2021;3(6):100459. doi:10.1016/j.ajogmf.2021.100459

51. Huang H, Tabb KM, Cerimele JM, Ahmed N, Bhat A, Kester R. Collaborative care for women with depression: a systematic review. Psychosomatics. 2017;58(1):11–18. doi:10.1016/j.psym.2016.09.002

52. Moore Simas TA, Flynn MP, Kroll-Desrosiers AR, et al. A systematic review of integrated care interventions addressing perinatal depression care in ambulatory obstetric care settings. Clin Obstet Gynecol. 2018;61(3):573–590. doi:10.1097/GRF.0000000000000360

53. Miller ES, Jensen R, Hoffman MC, et al. Implementation of perinatal collaborative care: a health services approach to perinatal depression care. Prim Health Care Res Dev. 2020;21:e30. doi:10.1017/S1463423620000110

54. Miller ES, Grobman WA, Ciolino JD, et al. Increased depression screening and treatment recommendations after implementation of a perinatal collaborative care program. Psychiatr Serv Wash DC. 2021;72(11):1268–1275. doi:10.1176/appi.ps.202000563

55. Snowber K, Ciolino JD, Clark CT, Grobman WA, Miller ES. Associations between implementation of the collaborative care model and disparities in perinatal depression care. Obstet Gynecol. 2022;140(2):204–211. doi:10.1097/AOG.0000000000004859

56. Rao WW, Zhu XM, Zong QQ, et al. Prevalence of prenatal and postpartum depression in fathers: a comprehensive meta-analysis of observational surveys. J Affect Disord. 2020;263:491–499. doi:10.1016/j.jad.2019.10.030

57. Paulson JF, Bazemore SD. Prenatal and postpartum depression in fathers and its association with maternal depression: a meta-analysis. JAMA. 2010;303(19):1961–1969. doi:10.1001/jama.2010.605

58. Cameron EE, Sedov ID, Tomfohr-Madsen LM. Prevalence of paternal depression in pregnancy and the postpartum: an updated meta-analysis. J Affect Disord. 2016;206:189–203. doi:10.1016/j.jad.2016.07.044

59. Luoma I, Puura K, Mäntymaa M, Latva R, Salmelin R, Tamminen T. Fathers’ postnatal depressive and anxiety symptoms: an exploration of links with paternal, maternal, infant and family factors. Nord J Psychiatry. 2013;67(6):407–413. doi:10.3109/08039488.2012.752034

60. Goodman JH. Paternal postpartum depression, its relationship to maternal postpartum depression, and implications for family health. J Adv Nurs. 2004;45(1):26–35. doi:10.1046/j.1365-2648.2003.02857.x

61. Dennis CL, Ross L. Women’s perceptions of partner support and conflict in the development of postpartum depressive symptoms. J Adv Nurs. 2006;56(6):588–599. doi:10.1111/j.1365-2648.2006.04059.x

62. Musser AK, Ahmed AH, Foli KJ, Coddington JA. Paternal postpartum depression: what health care providers should know. J Pediatr Health Care off Publ Natl Assoc Pediatr Nurse Assoc Pract. 2013;27(6):479–485. doi:10.1016/j.pedhc.2012.10.001

63. Paulson JF, Keefe HA, Leiferman JA. Early parental depression and child language development. J Child Psychol Psychiatry. 2009;50(3):254–262. doi:10.1111/j.1469-7610.2008.01973.x

64. Sethna V, Murray L, Edmondson O, Iles J, Ramchandani PG. Depression and playfulness in fathers and young infants: a matched design comparison study. J Affect Disord. 2018;229:364–370. doi:10.1016/j.jad.2017.12.107

65. Cochran SV, Rabinowitz FE. Gender-sensitive recommendations for assessment and treatment of depression in men. Prof Psychol Res Pract. 2003;34(2):132–140. doi:10.1037/0735-7028.34.2.132

66. Fisher SD, Cobo J, Figueiredo B, et al. Expanding the international conversation with fathers’ mental health: toward an era of inclusion in perinatal research and practice. Arch Womens Ment Health. 2021;24(5):841–848. doi:10.1007/s00737-021-01171-y

67. Lewkowitz AK, Griffin LB, Miller ES, Howard ED. A missed opportunity? How prenatal care, birth hospitalization, and digital health could increase nonbirthing partners’ access to recommended medical and mental healthcare. J Perinat Neonatal Nurs. 2022;36(4):330–334. doi:10.1097/JPN.0000000000000688

68. Ayala NK, Whelan AR, Recabo O, et al. Dispositional optimism, mode of delivery, and perceived labor control among recently delivered parturients. Am J Perinatol. 2022. doi:10.1055/a-1882-9940

69. Hu T, Zhang D, Wang J. A meta-analysis of the trait resilience and mental health. Personal Individ Differ. 2015;76:18–27. doi:10.1016/j.paid.2014.11.039

70. Rutten BPF, Hammels C, Geschwind N, et al. Resilience in mental health: linking psychological and neurobiological perspectives. Acta Psychiatr Scand. 2013;128(1):3–20. doi:10.1111/acps.12095

Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.